D. Lawrence

发表

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Length of survival of patients with cancer in hospice: a retrospective analysis of patients treated at a major cancer center versus other practice settings.

D. Lawrence, T. Younis, R. Milch, 2007, Journal of palliative medicine.

GATA2 deficiency syndrome: A decade of discovery

Anna L. Brown, H. Scott, P. Arts, 2021, Human mutation.

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.

C. Bloomfield, K. Mrózek, R. Mayer, 1997, Blood.

Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response

M. Czuczman, P. Wallace, A. Chanan-Khan, 2012, Cancer.

Cytogenetic Subtype Cytarabine Intensification in Acute Myeloid Leukemia Varies by Frequency of Prolonged Remission Duration after High-Dose Updated

C. Bloomfield, J. Byrd, S. Patil, 2006 .

High‐dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis

S. Sait, M. Wetzler, M. Baer, 2001, American journal of hematology.

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics

M. Czuczman, A. Chanan-Khan, F. Hernandez-Ilizaliturri, 2010, Leukemia & lymphoma.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

C. Bloomfield, J. Byrd, S. Patil, 1998, Cancer research.

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.

C. Bloomfield, K. Mrózek, S. Bigner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Morphologic characteristics of acute lymphoblastic leukemia (ALL) with abnormalities of chromosome 8, band q24

C. Bloomfield, C. Schiffer, M. L. Le Beau, 1992, American journal of hematology.

Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry

C. Bloomfield, C. Schiffer, K. Mrózek, 1998, Leukemia.

Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

C. Bloomfield, J. Byrd, D. Arthur, 1997, Blood.

Trisomy 13: A New Recurring Chromosome Abnormality in Acute Leukemia

C. Bloomfield, H. Döhner, J. Testa, 1990 .

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

M. Czuczman, K. Takeshita, P. Wallace, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trisomy 13: a new recurring chromosome abnormality in acute leukemia.

C. Bloomfield, H. Döhner, J. Testa, 1990, Blood.

Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors.

M. Czuczman, P. McCarthy, B. Bambach, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.

Z. Xia, S. Sait, H. Baumann, 2001, Leukemia research.

Thrombotic Microangiopathy after Allogeneic Blood and Marrow Transplantation Is Associated with Dose-Intensive Myeloablative Conditioning Regimens, Unrelated Donor, and Methylprednisolone T-Cell Depletion

M. Czuczman, P. McCarthy, B. Bambach, 2004, Transplantation.

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.

M. Caligiuri, C. Bloomfield, A. de la Chapelle, 1998, Cancer research.

Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study

C. Bloomfield, M. Qumsiyeh, K. Mrózek, 1998, British journal of haematology.

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.

C. Bloomfield, K. Mrózek, R. Mayer, 1997, Blood.

Clinical Efficacy of Lenalidomide {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of a Phase II Clinical Trial.

M. Czuczman, K. Takeshita, A. Chanan-Khan, 2006 .

Results of Phase II Study of Lenalidomide (L) {Revlimid ® } in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).

M. Czuczman, K. Takeshita, P. Wallace, 2005 .

Presenting Stage in Colon Cancer is Associated with Insurance Status

D. Lawrence, P. Dale, Betsy E. Smith, 2017, The American surgeon.

Lenalidomide (L) induces high response rates with molecular remission in patients (pts) with relapsed (rel) or refractory (ref) chronic lymphocytic leukemia (CLL).

M. Czuczman, K. Takeshita, A. Chanan-Khan, 2006, Journal of Clinical Oncology.

Length of Survival in Hospice for Cancer Patients Referred From a Comprehensive Cancer Center

D. Lawrence, T. Younis, R. Milch, 2009, The American journal of hospice & palliative care.